结核疫苗开发格局的概述
1ICMR-National Institute for Research in Tuberculosis, Chetpet, Chennai, India.
The Indian journal of tuberculosis
|September 20, 2025
概括
开发新的结核病 (TB) 疫苗对于消除结核病至关重要. 针对不同年龄组的多种候选疫苗正在临床试验中,以解决当前BCG疫苗的局限性.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 传染病流行病学 传染病流行病学
- 公共卫生 公共卫生
背景情况:
- 目前的BCG疫苗在预防所有年龄段的结核病 (TB) 疾病方面存在局限性.
- 实现结核病消除需要新型疫苗来减少结核病发病率.
研究的目的:
- 审查目前正在临床开发中的新型结核疫苗的情况.
- 突出开发有效结核病疫苗的各种方法和挑战.
主要方法:
- 在临床开发中对结核病疫苗的审查 (I-III阶段).
- 疫苗按类型 (病毒载体,真菌菌,蛋白质亚单元,mRNA) 和预期用途 (预防,治疗) 分类.
- 评估加速结核病疫苗开发的战略.
主要成果:
- 大约17种结核病疫苗正处于各种临床试验阶段.
- 候选疫苗代表不同的平台,针对结核病的不同阶段.
- 此外,BCG再接种疫苗也在调查中.
结论:
- 开发成功的结核病疫苗需要在基础科学,临床开发和公共卫生研究方面采取综合努力.
- 利益相关者的参与,资金和宣传对于加速推出新的结核病疫苗至关重要.
相关概念视频
Pulmonary Tuberculosis IV
479
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
479
Pulmonary Tuberculosis V
543
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
543
Pulmonary Tuberculosis I
844
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
844
Pulmonary Tuberculosis II
1.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K
Pulmonary Tuberculosis III
941
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
941
Microorganisms in Medicine and Therapeutics
987
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
987


